Table 4 Post-operative and long-term complications
|  | All patients (n = 65) | LGEA (n = 13) | Non-LGEA (n = 52) | p value* |
|---|---|---|---|---|
Mortality | 7 (10.8%) | 1 (7.7%) | 6 (11.5%) | 1.00 |
Surgical complications | 21 (32.3%) | 7 (53.8%) | 14 (26.9%) | 0.096 |
 Anastomotic stricture | 20 (30.8%) | 7 (53.8%) | 13 (25.0%) | 0.089 |
 Anastomotic leak | 4 (6.2%) | 3 (23.1%) | 1 (1.9%) | 0.023 |
 Recurrent TEF | 3 (4.6%) | 1 (7.7%) | 2 (3.8%) | 0.494 |
Gastro-esophageal complications | 38 (58.5%) | 10 (76.9%) | 28 (53.8%) | 0.209 |
 GERD | 28 (43.1%) | 8 (61.5%) | 20 (38.5%) | 0.210 |
 Dysphagia | 20 (30.8%) | 2 (15.4%) | 18 (34.6%) | 0.314 |
 Esophagitis | 4 (6.2%) | 0 | 4 (7.7%) | 0.576 |
Respiratory complications | 42 (64.6%) | 7 (53.8%) | 35 (67.3%) | 0.518 |
 Chronic cough | 19 (29.2%) | 0 | 19 (36.5%) | 0.007 |
 Pneumonia | 19 (29.2%) | 7 (53.8%) | 12 (23.1%) | 0.042 |
 Recurrent RTI | 23 (35.3%) | 4 (30.8%) | 19 (36.5%) | 0.758 |
 Asthma/BHR | 13 (20%) | 1 (7.7%) | 12 (23.1%) | 0.438 |
 Bronchiectasis | 3 (4.6%) | 1 (7.7%) | 2 (3.8%) | 0.494 |
 Tracheomalacia | 22 (33.8%) | 1 (7.7%) | 21 (40.4%) | 0.046 |
Interventions | ||||
 Dilatations for AS, median (IQR) | 5 (3–5) | 4.5 (2.75–8) | 5.5 (3.25–8) | 0.671 |
 Anti-reflux medicationsa | 48 (73.8%) | 12 (92.3%) | 36 (69.2%) | 0.157 |
 Fundoplication performed | 9 (13.8%) | 4 (30.8%) | 5 (9.6%) | 0.070 |
 Bronchodilatorsb | 15 (23.1%) | 1 (7.7%) | 14 (26.9%) | 0.268 |